These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 15578450)

  • 1. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
    Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
    Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
    Larson LJ; Schultz RD
    Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
    Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
    Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
    Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H
    Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroconversion of puppies to canine parvovirus and canine distemper virus: a comparison of two combination vaccines.
    Coyne MJ
    J Am Anim Hosp Assoc; 2000; 36(2):137-42. PubMed ID: 10730624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoughts on vaccination protocols.
    Petzel B
    J Am Vet Med Assoc; 2000 Nov; 217(10):1459. PubMed ID: 11128531
    [No Abstract]   [Full Text] [Related]  

  • 9. Thoughts on vaccination protocols.
    McLaughlin MA
    J Am Vet Med Assoc; 2000 Nov; 217(10):1458-9. PubMed ID: 11128530
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins.
    Pardo MC; Bauman JE; Mackowiak M
    Am J Vet Res; 1997 Aug; 58(8):833-6. PubMed ID: 9256965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of immunity against canine distemper, adenovirus and parvovirus after vaccination with two multivalent canine vaccines.
    Cunha RDS; da Silva Junior CL; Costa CA; de Aguiar HM; Junqueira Júnior DG
    Vet Med Sci; 2020 Aug; 6(3):330-334. PubMed ID: 32338828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
    Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a modified live, canine origin parvovirus vaccine.
    Bass EP; Gill MA; Beckenhauer WH
    J Am Vet Med Assoc; 1982 Nov; 181(9):909-13. PubMed ID: 7141990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing views of revaccination strategies.
    Palmquist R
    J Am Vet Med Assoc; 2000 Dec; 217(12):1789-91. PubMed ID: 11132877
    [No Abstract]   [Full Text] [Related]  

  • 15. Canine parvovirus vaccination.
    Atkinson M
    Vet Rec; 2006 Dec 23-30; 159(26):895; author reply 895-6. PubMed ID: 17189604
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines.
    Bergman JG; Muniz M; Sutton D; Fensome R; Ling F; Paul G
    Vet Rec; 2006 Nov; 159(22):733-6. PubMed ID: 17127756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
    Litster A; Nichols J; Volpe A
    Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
    Siedek EM; Schmidt H; Sture GH; Raue R
    Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Booster effect of canine distemper, canine parvovirus infection and infectious canine hepatitis combination vaccine in domesticated adult dogs.
    Taguchi M; Namikawa K; Maruo T; Orito K; Lynch J; Tsuchiya R; Sahara H
    Microbiol Immunol; 2012 Aug; 56(8):579-82. PubMed ID: 22672137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and serological response of wild dogs (Lycaon pictus) to vaccination against canine distemper, canine parvovirus infection and rabies.
    van Heerden J; Bingham J; van Vuuren M; Burroughs RE; Stylianides E
    J S Afr Vet Assoc; 2002 Mar; 73(1):8-12. PubMed ID: 12088076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.